Interní Med. 2011; 13(6): 244-246

Warfarin - old friend

MUDr.Vladimír Tuka, Ph.D., MUDr.Tomáš Janota, CSc.
3. interní klinika VFN a 1. LF UK, Praha

Warfarin is a useful, widely spread and indispensable drug used for both the treatment of pulmonary embolism and deep vein thrombosis

as well as prevention of thromboembolic complications in patients with atrial fibrillation, mechanical heart valve or after major surgery.

Despite its widespread use spanning many years, mistakes in its application are still being made and can be life-threatening because of

the narrow therapeutic window of warfarin and its many interactions.

Keywords: warfarin, antithrombotic therapy, therapy management, risks

Published: June 20, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tuka V, Janota T. Warfarin - old friend. Interní Med. 2011;13(6):244-246.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hirsh J, Guyatt G, et al. Antithrombotic and thrombolytic therapy: American College of Chest Physicians EvidenceBased Clinical Practice Guidelines (8th Edition). Chest 2008; 133(Suppl 6): 110S-112S. Go to original source...
    2. Ansell J, Hirsh J, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(Suppl 6): 160S-198S. Go to original source...
    3. Gage BF, Fihn SD, et al. Management and dosing of warfarin therapy. Am J Med 2000; 109(6): 481-488. Go to original source... Go to PubMed...
    4. Camm AJ, Kirchhof P, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31(19): 2369-2429. Go to original source... Go to PubMed...
    5. Hirsh J, Guyatt G, et al. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(Suppl 6): 71S-109S. Go to original source...
    6. Aiyagari V, Testai FD. Correction of coagulopathy in warfarin associated cerebral hemorrhage. Curr Opin Crit Care 2009; 15(2): 87-92. Go to original source... Go to PubMed...
    7. Holmes DR Jr., Kereiakes DJ, et al. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol 2009; 54(2): 95-109. Go to original source... Go to PubMed...
    8. Johnson SG, Rogers K, et al. Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest 2008; 133(4): 948-954. Go to original source... Go to PubMed...
    9. Wijns W, Kolh P, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31(20): 2501-2555. Go to original source... Go to PubMed...
    10. Pieper PG, Balci A, et al. Pregnancy in women with prosthetic heart valves. Neth Heart J 2008; 16(12): 406-411. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.